Steris reports Q4 non-GAAP EPS of $2.83 and revenue of $1.59 billion, both below analyst expectations.
Steris posted fourth-quarter non-GAAP earnings per share of $2.83, missing estimates by $0.02. Revenue reached $1.59 billion, up 7.4% year-over-year but $10 million below forecasts.
The company’s board approved a new $1 billion share repurchase program. For fiscal 2027, Steris expects reported revenue growth of 7-8%.
No immediate market reaction was disclosed in the release.